2BB score and signals
Janux Therapeutics, Inc.’s current 2BB score is 52 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 61 | High |
| Momentum | 50 | Stable |
| Financial strength | 45 | Normal |
| Quality | 98 | Very Strong |
| Risk | 36 | Low |
Janux Therapeutics, Inc. (JANX) Stock Score & Signals
Janux Therapeutics, Inc. (JANX) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 52 out of 100.
Company facts
| Founded | 2017 |
| Employees | 113 |
| 52-week range | $12.12 – $35.25 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-24 | — | -0.5442 | — | $7.16M |
| 2026-11-04 | — | -0.4841 | — | $7.90M |
| 2026-08-11 | — | -0.392 | — | $16.82M |
| 2026-05-07 | -0.39 | -0.5369 | $3.73M | $3.91M |